144 ·Filed Jul 1, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
The pre-arranged 10b5-1 plan limits signaling value; monitor for actual execution in coming days. No material read-through to fundamentals given the plan's adoption date.
Latest settled — T+60d
AXSM ▼ -19.76% at T+60d
NEUTRAL call ✗ call lost -19.76% · α vs SPY -22.77% · entry $244.31 → $196.03
T+1d
—
call — · α —
—
due 3mo ago
T+5d
+1.90%
call +1.90% · α +0.97%
$248.95
settled 3mo ago
T+20d
-3.96%
call -3.96% · α -3.54%
$234.64
settled 2mo ago
T+60d
-19.76%
call -19.76% · α -22.77%
$196.03
settled 7d ago
Price Chart
Loading chart...
Executive Summary
CEO Herriot Tabuteau filed a Form 144 to sell 49,666 common shares (approx. $11.9M) under a Rule 10b5-1 plan adopted on 3/10/2026. The sale is pre-arranged and part of a planned diversification, reducing concern of opportunistic insider selling.
Key Facts
- CEO Herriot Tabuteau intends to sell 49,666 shares of common stock (~$11.95M).
- Sale is under a 10b5-1 trading plan adopted on 3/10/2026.
- Shares acquired as compensation (stock options) on 3/15/2017.
- Recent insider selling (30d): 6 sells totaling $20.3M.
Financial Impact
~$11.95M in potential selling pressure, but pre-planned and small relative to $12.6B market cap (0.09%).
dilutioninsider selling
Risk Factors
- Potential overhang if large sell orders hit market, though planned nature mitigates signal.
- CEO reducing stake may reflect personal diversification, not company outlook.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001958244-26-000417 |
| Document: 0001958244-26-000417-index.html | 0001958244-26-000417 |
| Document: 0001958244-26-000417.txt | 0001958244-26-000417 |
23 reports for AXSM
83% Hit rate best @ T+60▲ +14.74%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $179.25 (−16.50%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $179.25 (−24.54%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $179.25 (−28.00%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $179.25 (−28.23%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $179.25 (−26.63%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $179.25 (−29.26%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Mon (64h 3m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access